NCT04607239

The Impact of Telemonitoring in the Management of Hypertension

HOme telemonitoRing of Arterial hypertensiOn With antihypertenSive Treatment Titration: a Randomized COntrolled prosPEctive Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 460 (estimated)
• Sponsor: Les Laboratoires des Médicaments Stériles · Industry
• Sex: All
• Age: 35 Years
• Healthy volunteers: Not accepted

Summary

Rater blinded, multi-center, prospective, randomized controlled study comparing mean 24 hour systolic blood pressure of eligible hypertensive patients in the TELEMONITORIN group versus the USUAL CARE group, at 6 months after inclusion.

Conditions

• Health Services Administration
• Telemedicine
• Hypertension

Interventions

Type	Name	Description
PROCEDURE	Telemonitoring	* A weekly telephone call by the CRA for the collection of home blood pressure measurements (which the patient measures twice a day everyday), for therapeutic education, and for treatment compliance assessment. * A monthly call by the attending physician for treatment titration and side effects check.
PROCEDURE	Usual Care without Telemonitoring	* Attending the follow up visits after inclusion at Day 90 (D-90) \& Day 180 (D-180) for face to face consultation with the attending physician. * Usual care without any phone calls for therapeutic education, treatment compliance assessment, treatment titration or side effects check.

Timeline

• Start date: 2020-07-04
• Primary completion: 2021-07-30
• Completion: 2021-07-30
• First posted: 2020-10-29
• Last updated: 2020-11-24

Locations

1 site across 1 country: Tunisia